Business »  Topic »  USFDA move not to hurt growth, new product nods to be delayed: Aurobindo

USFDA move not to hurt growth, new product nods to be delayed: Aurobindo


The company's stock took a beating after the USFDA pointed out data integrity lapses at the firm's formulations facility in Telangana's Bachupally

Message: Recipients' Email: Type address separated by commas
Your Email: Enter the characters shown in the image.
Send me a copy:

Read the full text business-standard